A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants

NCT06752174 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: sIPV+bOPV
BIOLOGICAL: wIPV+bOPV

Sponsor

Beijing Minhai Biotechnology Co., Ltd